Taraneh Yazdanparast | Medicine | Best Researcher Award

Best Researcher Award

Taraneh Yazdanparast

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences

Taraneh Yazdanparast
Affiliation Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences
Country Iran
Scopus ID 55604155600
Documents 39
Citations 328
h-index 11
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0003-3310-5653

Taraneh Yazdanparast, affiliated with the Center for Research and Training in Skin Diseases and Leprosy at Tehran University of Medical Sciences, is recognized for scholarly contributions within the field of medicine. Her research portfolio demonstrates sustained engagement in dermatological and clinical investigations, reflected through peer-reviewed publications, citation impact, and international academic visibility. The Best Researcher Award acknowledges research excellence, scientific productivity, and contributions to advancing medical knowledge through evidence-based studies and interdisciplinary collaboration.[1][2]

Abstract

The Best Researcher Award recognizes Taraneh Yazdanparast for her contributions to medical science, particularly within dermatology and related clinical research disciplines. Her scholarly activities encompass the development, evaluation, and dissemination of evidence-based findings that support improved understanding of skin diseases and patient care. Through peer-reviewed publications, collaborative investigations, and academic engagement, she has contributed to the advancement of scientific knowledge while maintaining a measurable research impact. Bibliometric indicators, including publication output, citation performance, and research visibility, demonstrate a sustained commitment to scholarly excellence and continued contributions to the international medical research community.[1][2]

Keywords

Best Researcher Award, Taraneh Yazdanparast, Medicine, Dermatology Research, Clinical Studies, Tehran University of Medical Sciences, Scientific Excellence, Research Impact, Citation Analysis, Academic Recognition.

Introduction

Recognition through academic awards highlights the importance of sustained scientific achievement and knowledge dissemination. Researchers working within medical sciences contribute to improved healthcare outcomes through rigorous investigation and publication of findings. Taraneh Yazdanparast’s research activities exemplify these objectives by supporting scientific inquiry and advancing evidence-based understanding in dermatological and clinical medicine.[1]

Research Profile

Taraneh Yazdanparast is affiliated with the Center for Research and Training in Skin Diseases and Leprosy at Tehran University of Medical Sciences. Her academic profile demonstrates consistent engagement in medical research, supported by a documented publication record, international indexing, and measurable citation performance. Her work reflects active participation in scholarly communication and collaborative scientific investigations.[2]

Research Contributions

Research contributions associated with Taraneh Yazdanparast include investigations related to dermatological disorders, clinical management strategies, patient outcomes, and evidence-based healthcare practices. Her publications contribute to the scientific literature by addressing relevant medical challenges and expanding knowledge available to clinicians, researchers, and healthcare professionals engaged in skin disease research and treatment.[3]

Publications

The researcher has produced a portfolio of scholarly publications indexed in major academic databases. These publications encompass peer-reviewed articles and collaborative studies that contribute to the dissemination of scientific knowledge. The documented publication record supports visibility within the international research community and demonstrates continued academic productivity over time.[1][4]

Research Impact

Research impact can be evaluated through publication output, citation metrics, and scholarly influence. With 39 indexed documents, 328 citations, and an h-index of 11, the available indicators suggest meaningful engagement with the academic community. These metrics provide evidence of research visibility and demonstrate the relevance of published work within the broader field of medicine.[1]

Award Suitability

The Best Researcher Award is intended to recognize individuals who demonstrate excellence in research productivity, scientific quality, and contribution to knowledge advancement. Taraneh Yazdanparast’s publication record, citation performance, and sustained commitment to medical research align with these criteria. Her academic achievements support her suitability for recognition within international research award programs.[5]

Conclusion

Taraneh Yazdanparast has established a notable academic presence through contributions to medicine and dermatological research. Her scholarly output, research influence, and commitment to scientific inquiry demonstrate the qualities associated with distinguished research achievement. Recognition through the Best Researcher Award reflects the significance of her work and its contribution to the advancement of medical science and academic excellence.

References

  1. Elsevier. (n.d.). Scopus author details: Taraneh Yazdanparast, Author ID 55604155600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55604155600
  2. ORCID. (n.d.). Research profile of Taraneh Yazdanparast.
    https://orcid.org/0000-0003-3310-5653
  3. Yazdanparast, T., et al. (2018). Biophysical and ultrasonographic changes in lichen planus compared with uninvolved skin. The Journal of Dermatology.
    https://doi.org/10.1111/1346-8138.17824
  4. Google Scholar. (n.d.). Scholar profile and citation metrics of Taraneh Yazdanparast.
    https://scholar.google.com/citations?user=3sVlyLQAAAAJ&hl=en&oi=ao
  5. Scientific World Research Awards. (n.d.). Best Researcher Award evaluation and recognition framework.
    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en